GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PhoenixBio Co 6190.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

236

-3.28%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥1.57bn

FY2017FY2026

Net income

¥125.2m

FY2017FY2026

Free cash flow

¥56.4m

FY2017FY2026

Shareholders' equity

¥1.55bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥1.57bn¥1.54bn¥1.72bn¥2.12bn¥1.32bn¥1.01bn¥1.31bn¥1.23bn¥902.4m¥1.23bn
Research and development¥191.4m¥273.8m¥206.9m¥205.5m¥219.8m¥221.1m¥238.0m¥345.6m¥176.1m¥140.6m
Operating income¥82.8m−¥135.2m¥11.1m¥509.4m−¥392.1m−¥276.9m−¥415.0m−¥311.9m−¥268.6m¥350.2m
Net income¥125.2m−¥445.6m¥26.4m¥493.3m−¥388.0m−¥238.0m−¥415.0m−¥297.5m−¥270.8m¥128.3m
Diluted earnings per share30.77-109.496.37130.99-68.65-71.97-126.21-101.40-96.8641.75

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥2.19bn¥2.31bn¥2.74bn¥3.02bn¥2.28bn¥2.52bn¥2.78bn¥1.91bn¥2.17bn¥2.39bn
Cash and short-term investments¥1.15bn¥1.15bn¥1.39bn¥1.56bn¥1.33bn¥1.33bn¥1.78bn¥656.7m¥932.9m¥1.64bn
Total liabilities¥640.1m¥944.8m¥946.6m¥1.50bn¥1.45bn¥1.42bn¥1.62bn¥362.6m¥311.9m¥281.6m
Debt¥486.6m¥565.4m¥723.9m¥1.13bn¥1.04bn¥1.04bn¥1.32bn¥80.9m¥139.7m¥187.0m
Shareholders' equity¥1.55bn¥1.37bn¥1.80bn¥1.51bn¥828.2m¥1.09bn¥1.16bn¥1.54bn¥1.86bn¥2.10bn
Shares outstanding4m4m4m4m6m3m3m3m3m3m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥68.9m−¥73.0m−¥79.3m¥277.5m¥16.4m−¥101.9m−¥12.0m−¥159.0m−¥187.0m¥44.0m
Capital spending−¥12.4m−¥21.2m−¥38.8m−¥12.4m−¥6.8m−¥182.3m−¥30.0m−¥64.0m−¥5.0m−¥9.0m
Free cash flow¥56.4m−¥94.2m−¥118.1m¥265.1m¥9.6m−¥284.2m−¥42.0m−¥223.0m−¥192.0m¥35.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥259.0m¥364.8m¥444.4m¥356.1m¥400.3m¥398.1m¥355.0m¥339.0m
Operating income−¥93.4m¥14.2m¥62.9m−¥18.1m¥23.7m¥11.3m−¥54.5m¥49.4m
Net income−¥91.1m¥32.0m¥80.9m−¥6.9m¥19.2m−¥294.9m−¥26.0m−¥147.0m
Diluted earnings per share-22.387.8619.88-1.694.72-72.45-6.28-35.50
Total assets¥2.07bn¥2.19bn¥2.20bn¥2.10bn¥2.23bn¥2.31bn¥2.51bn¥2.53bn
Cash and short-term investments¥1.10bn¥1.15bn¥1.05bn¥912.4m¥1.04bn¥1.15bn¥1.14bn¥1.21bn
Debt¥180.0m¥360.1m¥180.0m¥360.0m¥180.0m¥432.1m¥180.0m¥440.0m
Shareholders' equity¥1.46bn¥1.55bn¥1.52bn¥1.38bn¥1.37bn¥1.37bn¥1.67bn¥1.69bn

Financial ratios

Data as of 30 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin5.3%-27.5%3.7%24.2%-29.6%-22.0%
Net margin8.0%-28.9%1.5%23.2%-29.3%-23.5%
Return on equity8.1%-32.6%1.5%32.6%-46.8%-21.8%
Return on assets5.7%-19.3%1.0%16.3%-17.0%-9.5%
Free cash flow yield7.2%-4.6%-3.5%27.7%1.5%8.7%
Revenue growth1.6%-10.1%-19.2%60.3%30.7%-22.6%
Earnings growth-128.1%-1789.5%-94.7%-227.2%63.0%-42.7%
Current ratio4.40x3.03x5.06x1.78x4.23x4.51x
Debt to equity0.23x0.32x0.30x0.60x1.12x0.85x
Equity ratio70.8%59.1%65.5%50.2%36.3%43.5%
Interest coverage17.25x-80.88x21.43x167.23x-411.82x-190.84x
R&D as a share of sales12.2%17.8%12.1%9.7%16.6%21.8%
Buybacks as a share of market value0.0%1.7%-9.9%33.4%-70.9%-0.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-9.7%9.1%2.6%
Operating income-45.4%—-8.0%
Net income-36.7%—0.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1.7%6.7%-2.2%-4.3%
Net margin-10.3%2.9%-4.6%-7.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings8.2-4.451.83.6-9.9-7.1-4.7-8.2-6.926.9
Price to sales0.71.30.80.82.91.71.52.02.12.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.